Microbial Biofilms: Challenges and Advances in Metabolomic Study is a volume in the Advances in Biotechnology and Bioengineering Series. The volume covers the metabolomic characteristics of bacterial biofilms and examines the techniques used in the analysis of the metabolomics of the biofilm, its formation, and related infections. The book includes the metabolomics study of various types of biofilms and details new strategies in targeting metabolic pathways for inhibiting the biofilm.
The book also describes various types of metabolomics studies like metabolomics of oral biofilm and metabolomics of biofilm by nosocomial microbes. It also points out the recent advancements on various aspects of metabolomics studies pertaining to biofilms, related infections, their pathogenesis, and present-day treatment strategies.
Microbial Biofilms: Challenges and Advances in Metabolomic Study is a helpful resource to scientists and researchers engaged in biofilm studies, precisely on the metabolomic changes at molecular level occurring in the participating microorganisms. It is also fascinating and thought provoking for the clinicians and health professionals actively involved in the treatment of biofilm mediated chronic infections, since it depicts the pathogenic consequences of the small molecular interactions of the metabolites in biofilm.
1. Chapter 3. Introduction on genomic analysis of biofilms - p. 39 2. Chapter 4. Metabolomic study of biofilm-forming natural microbiota of oral biofilm - p. 49 3. Chapter 5. From symbiosis to dysbiosis in gut-consequence includes metabolic syndrome - p. 61 4. Chapter 6. Metabolomic study of biofilm-forming natural microbiota of skin biofilm - p. 85 5. Chapter 7. Metabolomic study of biofilm-forming natural microbiota of vaginal biofilm - p. 105 6. Chapter 8. Metabolome analysis for host–microbiota interactions - p. 117 7. Chapter 9. Multispecies metabolomics interactions resulting in the development of resistance - p. 133 8. Chapter 10. Natural phytochemicals: a potential alternative antibiofilm agent - p. 151 9. Chapter 11. Medical devices–associated biofilm infections and challenges in treatment - p. 169 10. Chapter 12. NMR-based metabolomics study of microbial biofilm - p. 195 11. Chapter 13. Isotope labeling LC-MS for metabolomics of biofilm study and tracer-based biofilm metabolomics analysis - p. 217 12. Chapter 14. Lipidomics profiling of microbial biofilm - p. 225 13. Chapter 15. Functional metabolomics approaches in determining the inhibition of biofilm - p. 235 14. Chapter 16. Reprogramming the metabolomics of biofilms - p. 253 15. Chapter 17. Dysbiosis of microbiome: a risk factor for cancer, metabolic and inflammatory diseases - p. 267 16. Chapter 18. Strategies to reduce microbial biofilm in medical prosthesis and other devices - p. 289 17. Chapter 19. Targeting microbial biofilms using genomics-guided drug discovery - p. 315 18. Chapter 20. Biofilms: a sociomicrobiological nexus - p. 325 19. In silico and in vivo methods for designing antibiofilm agents against Pseudomonas aeruginosa and Staphylococcus aureus - p. 337 20. Chapter 22. Biofilm: a threat to medical devices - p. 369 21. Chapter 23. Biofilm formation in acute and chronic respiratory infections caused by nosocomial gram-negative bacteria - p. 391 22. Index - p. 415
Microbial Biofilms: Challenges and Advances in Metabolomic Study is a volume in the Advances in Biotechnology and Bioengineering Series. The volume covers the metabolomic characteristics of bacterial biofilms and examines the techniques used in the analysis of the metabolomics of the biofilm, its formation, and related infections. The book includes the metabolomics study of various types of biofilms and details new strategies in targeting metabolic pathways for inhibiting the biofilm.
The book also describes various types of metabolomics studies like metabolomics of oral biofilm and metabolomics of biofilm by nosocomial microbes. It also points out the recent advancements on various aspects of metabolomics studies pertaining to biofilms, related infections, their pathogenesis, and present-day treatment strategies.
Microbial Biofilms: Challenges and Advances in Metabolomic Study is a helpful resource to scientists and researchers engaged in biofilm studies, precisely on the metabolomic changes at molecular level occurring in the participating microorganisms. It is also fascinating and thought provoking for the clinicians and health professionals actively involved in the treatment of biofilm mediated chronic infections, since it depicts the pathogenic consequences of the small molecular interactions of the metabolites in biofilm.
1. Chapter 3. Introduction on genomic analysis of biofilms - p. 39 2. Chapter 4. Metabolomic study of biofilm-forming natural microbiota of oral biofilm - p. 49 3. Chapter 5. From symbiosis to dysbiosis in gut-consequence includes metabolic syndrome - p. 61 4. Chapter 6. Metabolomic study of biofilm-forming natural microbiota of skin biofilm - p. 85 5. Chapter 7. Metabolomic study of biofilm-forming natural microbiota of vaginal biofilm - p. 105 6. Chapter 8. Metabolome analysis for host–microbiota interactions - p. 117 7. Chapter 9. Multispecies metabolomics interactions resulting in the development of resistance - p. 133 8. Chapter 10. Natural phytochemicals: a potential alternative antibiofilm agent - p. 151 9. Chapter 11. Medical devices–associated biofilm infections and challenges in treatment - p. 169 10. Chapter 12. NMR-based metabolomics study of microbial biofilm - p. 195 11. Chapter 13. Isotope labeling LC-MS for metabolomics of biofilm study and tracer-based biofilm metabolomics analysis - p. 217 12. Chapter 14. Lipidomics profiling of microbial biofilm - p. 225 13. Chapter 15. Functional metabolomics approaches in determining the inhibition of biofilm - p. 235 14. Chapter 16. Reprogramming the metabolomics of biofilms - p. 253 15. Chapter 17. Dysbiosis of microbiome: a risk factor for cancer, metabolic and inflammatory diseases - p. 267 16. Chapter 18. Strategies to reduce microbial biofilm in medical prosthesis and other devices - p. 289 17. Chapter 19. Targeting microbial biofilms using genomics-guided drug discovery - p. 315 18. Chapter 20. Biofilms: a sociomicrobiological nexus - p. 325 19. In silico and in vivo methods for designing antibiofilm agents against Pseudomonas aeruginosa and Staphylococcus aureus - p. 337 20. Chapter 22. Biofilm: a threat to medical devices - p. 369 21. Chapter 23. Biofilm formation in acute and chronic respiratory infections caused by nosocomial gram-negative bacteria - p. 391 22. Index - p. 415
